Thursday, February 24, 2011

Eli Lilly & Co. paid $1.42 billion for its off-label marketing

Eli Lilly & Co. paid $1.42 billion for its off-label marketing Zyprexa.  Lilly trained its sales force to disregard the law by promoting Zyprexa for off-label uses.  For over two years, Lilly earned “hundreds of millions of dollars” through consistent criminal violations of the Food, Drug, and Cosmetic Act.  Click here for  DoJ press release.

No comments:

Post a Comment